Biocompatibility of chitosan-coated iron oxide nanoparticles with osteoblast cells

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5593-5602

  Shi, Si Feng ^a   Jia, Jing Fu ^b   Guo, Xiao Kui ^c   Zhao, Ya Ping ^b   Chen, De Sheng ^a   Guo, Yong Yuan ^a   Cheng, Tao ^a   Zhang, Xian Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chitosan coated iron oxide; Magnetic nanoparticles; Osteoblasts

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CHITOSAN; FERRIC FERROCYANIDE; LACTATE DEHYDROGENASE; MAGNETIC NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; BIOCOMPATIBILITY; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR TRANSPORT; MAGNETOMETRY; MEMBRANE DAMAGE; OSTEOBLAST; PROTEIN SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHITOSAN; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; MAGNETITE NANOPARTICLES; MATERIALS TESTING; OSTEOBLASTS;

EID: 84870352914     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34348     Document Type: Article

References (35)

1. Sanchez-Riera L, Wilson N, Kamalaraj N, etal. Osteoporosis and fragility fractures. Best Pract Res Clin Rheumatol. 2010;24(6):793-810.
2. Becker DJ, Kilgore ML, Morrisey MA. The societal burden of osteoporosis. Curr Rheumatol Rep. 2010;12(3):186-191.
3. Dempster DW. Osteoporosis and the burden of osteoporosis-related fractures. Am J Manag Care. 2011;17 Suppl 6:S164-S169.
4. Ascenzi MG, Liao VP, Lee BM, etal. Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis. J Bone Miner Res. 2012;27(3):702-712.
5. Kraenzlin ME, Meier C. Parathyroid hormone analogues in the treatment of osteoporosis. Nat Rev Endocrinol. 2011;7(11):647-656.
6. Shen L, Xie X, Su Y, Luo C, Zhang C, Zeng B. Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials. PLoS One. 2011;6(10):e26267.
7. Seeman E, Eisman JA. Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. Med J Aust. 2004;180(6):298-303.
8. Pareta RA, Taylor E, Webster TJ. Increased osteoblast density in the presence of novel calcium phosphate coated magnetic nanoparticles. Nanotechnology. 2008;19(26):265101.
9. Adami S, Zamberlan N. Adverse effects of bisphosphonates. A comparative review. Drug Saf. 1996;14(3):158-170.
10. Polyak B, Friedman G. Magnetic targeting for site-specific drug delivery: applications and clinical potential. Expert Opin Drug Deliv. 2009;6(1):53-70.
11. Voltairas PA, Fotiadis DI, Michalis LK. Hydrodynamics of magnetic drug targeting. J Biomech. 2002;35(6):813-821.
12. Alexiou C, Jurgons R, Schmid RJ, etal. Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment. J Drug Target. 2003;11(3):139-149.
13. Jones GL, Motta A, Marshall MJ, El Haj AJ, Cartmell SH. Osteoblast: osteoclast co-cultures on silk fibroin, chitosan and PLLA films. Biomaterials. 2009;30(29):5376-5384.
14. Mathews S, Gupta PK, Bhonde R, Totey S. Chitosan enhances mineralization during osteoblast differentiation of human bone marrow-derived mesenchymal stem cells, by upregulating the associated genes. Cell Prolif. 2011;44(6):537-549.
15. Heinemann C, Heinemann S, Bernhardt A, Worch H, Hanke T. Novel textile chitosan scaffolds promote spreading, proliferation, and differentiation of osteoblasts. Biomacromolecules. 2008;9(10):2913-2920.
16. Cai K, Hu Y, Jandt KD, Wang Y. Surface modification of titanium thin film with chitosan via electrostatic self-assembly technique and its influence on osteoblast growth behavior. J Mater Sci Mater Med. 2008;19(2):499-506.
17. Shi C, Zhu Y, Ran X, Wang M, Su Y, Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res. 2006;133(2):185-192.
18. Zhu XM, Wang YX, Leung KC, etal. Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines. Int J Nanomedicine. 2012;7:953-964.
19. Mou Y, Hou Y, Chen B, etal. In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide. Int J Nanomedicine. 2011;6:2633-2640.
20. Li Y, Yao Y, Sheng Z, Yang Y, Ma G. Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction. Int J Nanomedicine. 2011;6:815-823.
21. Chen R, Yu H, Jia ZY, Yao QL, Teng GJ. Efficient nano iron particle-labeling and noninvasive MR imaging of mouse bone marrow-derived endothelial progenitor cells. Int J Nanomedicine. 2011;6:511-519.
22. Wang L, Wang ZH, Shen CY, You ML, Xiao JF, Chen GQ. Differentiation of human bone marrow mesenchymal stem cells grown in terpolyesters of 3-hydroxyalkanoates scaffolds into nerve cells. Biomaterials. 2010;31(7):1691-1698.
23. Tran N, Webster TJ. Increased osteoblast functions in the presence of hydroxyapatite-coated iron oxide nanoparticles. Acta Biomater. 2011;7(3):1298-1306.
24. Zhang Y, Shi B, Li C, etal. The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds. J Control Release. 2009;136(3):172-178.
25. Haidar ZS, Azari F, Hamdy RC, Tabrizian M. Modulated release of OP-1 and enhanced preosteoblast differentiation using a core-shell nanoparticulate system. J Biomed Mater Res A. 2009;91(3):919-928.
26. Zhao G, Schwartz Z, Wieland M, etal. High surface energy enhances cell response to titanium substrate microstructure. J Biomed Mater Res A. 2005;74(1):49-58.
27. Khang D, Lu J, Yao C, Haberstroh KM, Webster TJ. The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials. 2008;29(8):970-983.
28. Price RL, Ellison K, Haberstroh KM, Webster TJ. Nanometer surface roughness increases select osteoblast adhesion on carbon nanofiber compacts. J Biomed Mater Res A. 2004;70(1):129-138.
29. Osaka T, Nakanishi T, Shanmugam S, Takahama S, Zhang H. Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. Colloids Surf B Biointerfaces. 2009;71(2):325-330.
30. Ortega D, Velez-Fort E, Garcia DA, etal. Size and surface effects in the magnetic properties of maghemite and magnetite coated nanoparticles. Philos Transact A Math Phys Eng Sci. 2010;368(1927):4407-4418.
31. Selvan ST. Silica-coated quantum dots and magnetic nanoparticles for bioimaging applications. Biointerphases. 2010;5(3):FA110-FA115.
32. Nam HY, Kwon SM, Chung H, etal. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release. 2009;135(3):259-267.
33. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res. 2000;51(3):475-483.
34. Webster TJ, Schadler LS, Siegel RW, Bizios R. Mechanisms of enhanced osteoblast adhesion on nanophase alumina involve vitronectin. Tissue Eng. 2001;7(3):291-301.
35. Ma J, Wang H, He B, Chen J. A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosan bilayer material as a scaffold of human neofetal dermal fibroblasts. Biomaterials. 2001;22(4):331-336.